Moleculin Biotech, Inc. Debt Conversion, Original Debt, Amount
Moleculin Biotech, Inc. (MBRX) reported Debt Conversion, Original Debt, Amount of $300.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2018-03-28
- Moleculin Biotech, Inc. debt conversion, original debt, amount for the quarter ending 2017-06-30 was -$20.00K.
- Moleculin Biotech, Inc. debt conversion, original debt, amount for the quarter ending 2017-03-31 was $320.00K.
- Moleculin Biotech, Inc. debt conversion, original debt, amount for the quarter ending 2016-12-31 was $21.58K.
- Moleculin Biotech, Inc. debt conversion, original debt, amount for fiscal 2016 was $155.56K.
| Period end | Debt Conversion, Original Debt, Amount | Debt Conversion, Original Debt, Amount 1 month | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|---|---|
| 2017-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $300.00K 10-Q · filed 2017-08-11 | $321.58K derived: sum of 3 quarters · filed 2018-03-28 | |||
| 2017-03-31 | $320.00K 10-Q · filed 2017-05-12 | $341.58K derived: sum of 2 quarters · filed 2018-03-28 | ||||
| 2016-12-31 | $21.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $155.56K 10-K · filed 2018-03-28 | ||||
| 2016-09-30 | $133.99K 10-Q · filed 2016-11-21 | |||||
| 2016-05-31 | $183.36K 10-K · filed 2018-03-28 | $183.36K 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |